Introduction: Percutaneous mitral balloon valvotomy (PMBV) has emerged as an alternative to surgical treatment of mitral stenosis. Objective: To identify the independents predictors of death and combined events (death, new mitral balloon valvotomy, or mitral valve surgery) in long-term follow-up of patients undergoing PMBV. Methods: From 1987 to 2011 a total of 312 patients were followed-up 54.0AE31.0 (1 to 126) months. The techniques were the single-balloon (84.4%), Inoue-balloon (13.8%), and double-balloon techniques (1.7%). The total group was divided in two: echocardiographic score >8 and 8 points groups. Multivariate Cox regression analysis was performed to identify independent risk factors of long-term survival and event free survival. Results: The mean age was 38.0AE12.6 years old (range, 13 to 83). Before the procedure, 84,42% patients had echo score 8, and 15.57% score> 8. Females comprised 85%, and 84% patients were in sinus rhythm. During follow-up, survival of the total group was 95.5%, echo score group 8 was 98.0% and echo score > 8 was 82.2% (p<0.0001), whereas combined event-free survival was 83.4%, 86.1%, and 68.9%, respectively (p<0.0001). In multivariate analysis, independent risk factors of death were pre procedure echo score > 8 and the presence of severe mitral valve regurgitation during the procedure. The predictors of combined events were a previous history of mitral valvular commissurotomy, atrial fibrillation, the presence of severe mitral valve regurgitation during the procedure and post procedure mitral valve area < 1.5 m 2 . Conclusion: PMBV is an effective procedure. Survival was high, even higher in the group with lower echocardiographic scores. Over 2/3 of the patients were event-free at the end of follow-up. Independents predictors of survival were pre procedure echo score 8 and the absence of severe mitral valve regurgitation during the procedure. 
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